Skip to content

Inclusive analysis of micro RNA in blood products with next generation sequencer

Inclusive analysis of micro RNA in blood products with next generation sequencer - Inclusive analysis of micro RNA in blood products with next generation sequencer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000021538
Enrollment
20
Registered
2016-05-01
Start date
2016-05-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The patinets who may receive blood transfusion therapy.

Interventions

None listed

Sponsors

Department of Anesthesiology, Kyoto Prefectural University of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy person who weighs over 50kg.

Exclusion criteria

Exclusion criteria: 1) The person who has the following medical history-cardiac diasease, malignant tumor, hematologic disease, asthma, allergic disease, cerebrovascular disease, nephrotic syndrome, viral hepatitis/HIV 2) The person who donates blood over three times per one year.

Design outcomes

Primary

MeasureTime frame
the time-dependent changes of micro RNA in blood products

Countries

Japan

Contacts

Public ContactYoshinobu Nakayama

Kyoto Prefectural University of Medicine Department of Anesthesiology

na-yoshi@koto.kpu-m.ac.jp075-251-5633

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026